LIPAC Oncology to Present at Upcoming Investor Conferences

MENLO PARK, Calif.: MENLO PARK, Calif., Sept. 21, 2021 /PRNewswire/ -- LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced that management will participate in the following investor conferences, which will all be...

Click to view original post